Member Exclusive

Novel strategy to develop stable peptide drugs

Researchers at the École Polytechnique Fédérale de Lausanne (Switzerland) have used cysteine bridges to create complex, stable peptide structures that are able to bind to specific motifs and modulate protein activity.

Go to the profile of Benjamin Walden
May 02, 2018

Please sign in or register for FREE

Register to MedChemNet

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.